Skip to main content

Table 5 Total frequencies of conventional synthetic and biological DMARDs in the REAL cohort

From: Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study

DMARDN (%)
Methotrexate748 (66.5)
Leflunomide381 (33.9)
Hydroxychloroquine120 (10.7)
Sulfasalazine55 (4.9)
Abatacept73 (6.5)
Etanercept66 (5.9)
Tocilizumab60 (5.3)
Adalimumab54 (4.8)
Infliximab50 (4.4)
Rituximab49 (4.4)
Golimumab37 (3.3)
Certolizumab17 (1.5)